Search filters

List of works by Michela Del Prete

5-Fluorouracil pharmacogenomics: still rocking after all these years?

scientific article published on February 2011

Angiogenesis genotyping and clinical outcome during regorafenib treatment in metastatic colorectal cancer patients.

scientific article published on 27 April 2016

Angiogenesis genotyping in the selection of first-line treatment with either sunitinib or pazopanib for advanced renal cell carcinoma.

scientific article published on 09 May 2016

Angiogenetic pathway as a therapeutic target in renal cell carcinoma

scientific article published on 01 February 2012

Beyond RAS: the role of epidermal growth factor receptor (EGFR) and its network in the prediction of clinical outcome during anti-EGFR treatment in colorectal cancer patients

scientific article

Cancer stem cell gene profile as predictor of relapse in high risk stage II and stage III, radically resected colon cancer patients

scientific article

Cinacalcet in the management of primary hyperparathyroidism: post marketing experience of an Italian multicentre group.

scientific article published on 27 April 2013

Clinical evidence for three distinct gastric cancer subtypes: time for a new approach

scientific article

Combined biological therapy with lanreotide autogel and cabergoline in the treatment of MEN-1-related insulinomas

scientific article published on 03 January 2014

Hepatic arterial embolization in patients with neuroendocrine tumors

scientific article

Insulin resistance and acne: a new risk factor for men?

scientific article published on 25 March 2012

Lactate Dehydrogenase in Hepatocellular Carcinoma: Something Old, Something New

scientific article

Limitations of Chromogranin A in clinical practice

scientific article published on 06 February 2012

Mismatch repair deficiency may affect clinical outcome through immune response activation in metastatic gastric cancer patients receiving first-line chemotherapy.

scientific article published on 21 January 2016

Molecular biomarkers of resistance to anti-EGFR treatment in metastatic colorectal cancer, from classical to innovation

scientific article published on 24 June 2013

Multiple ovarian cysts in a young girl with severe hypothyroidism

scientific article published in December 2007

Novel perspectives for the treatment of gastric cancer: from a global approach to a personalized strategy.

scientific article published in May 2010

Off-target effects and clinical outcome in metastatic colorectal cancer patients receiving regorafenib: The TRIBUTE analysis

scientific article published on 05 April 2017

Personalized 177Lu-octreotate peptide receptor radionuclide therapy of neuroendocrine tumours: a simulation study.

scientific article published on 31 March 2017

Phosphorylated AKT and MAPK expression in primary tumours and in corresponding metastases and clinical outcome in colorectal cancer patients receiving irinotecan-cetuximab

scientific article

Potential role of cinacalcet hydrochloride in sporadic primary hyperparathyroidism without surgery indication

scientific article published on 15 August 2014

Prognostic Value for Incidental Antihypertensive Therapy With β-Blockers in Metastatic Colorectal Cancer.

scientific article

Prognostic clinical factors in pretreated colorectal cancer patients receiving regorafenib: implications for clinical management

scientific article published on 17 August 2015

Prognostic impact of mismatch repair genes germline defects in colorectal cancer patients: are all mutations equal?

scientific article published on 15 October 2015

Prognostic role of the CDNK1B V109G polymorphism in multiple endocrine neoplasia type 1.

scientific article published on 30 March 2015

Role of vascular endothelial growth factor (VEGF) and VEGF-R genotyping in guiding the metastatic process in pT4a resected gastric cancer patients

scientific article

Role of β4 integrin in HER-3-negative, K-RAS wild-type metastatic colorectal tumors receiving cetuximab

scientific article

Second-line sunitinib as a feasible approach for iodine-refractory differentiated thyroid cancer after the failure of first-line sorafenib

scientific article published on 11 October 2014

State of the art and future perspectives for the use of insulin-like growth factor receptor 1 (IGF-1R) targeted treatment strategies in solid tumors

scientific article published on February 1, 2011

Stricter criteria increase the validity of a quick intraoperative parathyroid hormone assay in primary hyperparathyroidism.

scientific article published in March 2009

The Role of Aspirin as Antitumoral Agent for Heavily Pretreated Patients With Metastatic Colorectal Cancer Receiving Capecitabine Monotherapy

scientific article published on 04 August 2016

The Tower of Babel of liver metastases from colorectal cancer: are we ready for one language?

scientific article published on 08 September 2012

The correlation between LDH serum levels and clinical outcome in advanced biliary tract cancer patients treated with first line chemotherapy.

scientific article published on 11 April 2016

The role of LDH serum levels in predicting global outcome in HCC patients undergoing TACE: implications for clinical management

scientific article

Three drugs vs two drugs first-line chemotherapy regimen in advanced gastric cancer patients: a retrospective analysis.

scientific article published on December 2015

Transarterial embolization (TAE) is equally effective and slightly safer than transarterial chemoembolization (TACE) to manage liver metastases in neuroendocrine tumors

scientific article published on 03 January 2014

Tumor angiogenesis genotyping and efficacy of first-line chemotherapy in metastatic gastric cancer patients

scientific article